Cargando…
Discrimination of approved drugs from experimental drugs by learning methods
BACKGROUND: To assess whether a compound is druglike or not as early as possible is always critical in drug discovery process. There have been many efforts made to create sets of 'rules' or 'filters' which, it is hoped, will help chemists to identify 'drug-like' molecul...
Autores principales: | Tang, Kailin, Zhu, Ruixin, Li, Yixue, Cao, Zhiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120701/ https://www.ncbi.nlm.nih.gov/pubmed/21569562 http://dx.doi.org/10.1186/1471-2105-12-157 |
Ejemplares similares
-
When drug discovery meets web search: Learning to Rank for ligand-based virtual screening
por: Zhang, Wei, et al.
Publicado: (2015) -
Screening Ingredients from Herbs against Pregnane X Receptor in the Study of Inductive Herb-Drug Interactions: Combining Pharmacophore and Docking-Based Rank Aggregation
por: Cui, Zhijie, et al.
Publicado: (2015) -
Screening of antibacterial compounds with novel structure from the FDA approved drugs using machine learning methods
por: Li, Wen-Xing, et al.
Publicado: (2022) -
Systemic neurotransmitter responses to clinically approved and experimental neuropsychiatric drugs
por: Noori, Hamid R., et al.
Publicado: (2018) -
Inferring Novel Indications of Approved Drugs via a Learning Method with Local and Global Consistency
por: Yan, Yan, et al.
Publicado: (2014)